+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sexually Transmitted Diseases (STD) Diagnostics Market 2019-2025

  • PDF Icon


  • November 2019
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 4893915
Sexually Transmitted Disease (STD) Diagnostics Market Size, Share & Trends Analysis Report, By Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus and Others), By Product (Laboratory Testing Devices and Point - Of - Care Testing Devices), By End - User (Hospitals and Clinics, Diagnostic Centers and Homecare) and Forecast 2019 - 2025.

The global sexually transmitted disease (STD) testing market is estimated to witness significant growth during the forecast period. The market growth is attributed to the increasing number of technologically advanced testing and diagnostics products that provide more precise testing results. In addition, a significant shift towards the adoption of point of care testing has been observed, that further fuel the growth of the global STD diagnostics market. Moreover, the supportive government policies for the betterment of healthcare infrastructure, especially in countries of Asia - Pacific and the Middle East and Africa, further gives a boost to the growth of the market.

Geographically, the market is divided into North America, Europe, Asia Pacific, and RoW. North America is expected to dominate the STD diagnostics market owing to cohesive government initiatives in the US for STD testing, favorable healthcare infrastructure and high awareness levels regarding STDs. However, Asia - Pacific is anticipated to be the fastest - growing region for the STD diagnosis market during the forecast period owing to the rapid spread of HPV and HIV infection in the region. India and China are the major economies that are contributing significantly to the regional growth of the market.

The major players profiled in the global STD diagnostics market include Abbott Laboratories, Inc., Bio - Rad Laboratories, Inc., F. Hoffman - La Roche Ltd., bioMerieux SA, Hologic Inc., and Danaher Corp. Mergers and acquisitions, product launch, and partnerships and collaborations are some of the major strategies adopted by the companies to expand their presence across the globe and gain a competitive advantage over other competitors. For instance, In October 2017, Abbot Laboratories closed the acquisition of Alere Inc., for5.3 billion. The transaction established Abbott as one of the global leaders in point of care testing market.

Research Methodology

The market study of the global STD diagnostics market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country - level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro - economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Authentic public databases such as WHO and the National Institute of Health
  • Whitepapers, research - papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for providers of STD diagnostic platforms and medical device manufacturers, suppliers and distributors, pharmaceutical companies, potential investors and venture capitalists, existing companies and new entrants, government agencies and other participants for overall market analysis and competitive analysis. The report provides in - depth analysis on market size, different products offered by the companies, and future market opportunities. The report will serve as a source for 360 - degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation
  • Global STD Diagnostics Market Research and Analysis, By Disease Type
  • Global STD Diagnostics Market Research and Analysis, By Product
  • Global STD Diagnostics Market Research and Analysis, By End - User

The Report Covers
  • Comprehensive research methodology of the global STD diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global STD diagnostics market.
  • Insights about market determinants which are stimulating the global STD diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Abbott Laboratories, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Bio-Rad Laboratories, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. F. Hoffmann-La Roche Ltd. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Becton, Dickinson, and Co. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. Danaher Corp. Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global STD Diagnostics Market by Disease Type
5.1.1. Chlamydia
5.1.2. Syphilis
5.1.3. Gonorrhea
5.1.4. Herpes Simplex Virus (HSV)
5.1.5. Human Papilloma Virus (HPV)
5.1.6. Human Immunodeficiency Virus (HIV)
5.1.7. Others
5.2. Global STD Diagnostics Market by Product
5.2.1. Laboratory Testing Devices
5.2.2. Point-of-Care (POC) Testing Devices
5.3. Global STD Diagnostics Market by End-User
5.3.1. Hospitals and Clinics
5.3.2. Diagnostic Centers
5.3.3. Homecare
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. AbbVie Inc.
7.3. AITbiotech Pte Ltd.
7.4. Becton, Dickinson and Co.
7.5. Binx Health, Inc.
7.6. Biocartis NV
7.7. bioMérieux SA
7.8. Bio-Rad Laboratories, Inc.
7.9. Bristol-Myers Squibb Co.
7.10. Danaher Corp.
7.11. DiaSorin S.p.A.
7.12. Eli Lilly and Co.
7.13. F. Hoffmann-La Roche Ltd.
7.14. GenMark Diagnostics, Inc.
7.15. Hologic, Inc.
7.16. Merck KGaA
7.17. NOWDiagnostics, Inc.
7.18. OraSure Technologies, Inc.
7.19. Qualigen, Inc.
7.20. Quidel Corp.
7.21. SpeeDx Pty. Ltd.
7.22. Thermo Fisher Scientific, Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • AbbVie Inc.
  • AITbiotech Pte Ltd.
  • Becton, Dickinson and Co.
  • Binx Health, Inc.
  • Biocartis NV
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Bristol-Myers Squibb Co.
  • Danaher Corp.
  • DiaSorin S.p.A.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • GenMark Diagnostics, Inc.
  • Hologic, Inc.
  • Merck KGaA
  • NOWDiagnostics, Inc.
  • OraSure Technologies, Inc.
  • Qualigen, Inc.
  • Quidel Corp.
  • SpeeDx Pty. Ltd.
  • Thermo Fisher Scientific, Inc.